← Leaderboards
Paul H Kussie
Translational Sciences, Inc.
$1,649,990
Attributed
$3,299,979
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1000K · FY2011–14$1M$750K$500K$250K$0
'11
'12
'13
'14
Funding mix
By agency
NIH$3,299,979 · 1
By mechanism
U44$3,299,979 · 1
Top collaborators
- Guy L Reed4 shared
Most similar at Translational Sciences, Inc.
Same institution · by research overlap
- Sun Yong Jeong$3,523,818
- Dong Wang$1,679,573
- Tieqiang Zhao$175,560
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAlteplaseAmericanAdverse EventAntiplasminBehaviorBinding (Molecular Function)BioreactorsAntibodiesBlood CoagulationBlood FlowBlood VesselsBrainCause Of DeathCell BankCessation Of LifeCgmp ProductionChinese Hamster Ovary CellClinical Trials DesignCoagulation ProcessCostCross ReactivityCytolysisDisability
Grant awards (4)
Reducing Stroke by a Novel, Clot-dissolving Antibody$999,993
U44 · FY2014 · NS
Reducing Stroke by a Novel, Clot-dissolving Antibody$999,993
U44 · FY2013 · NS · contact PI
Reducing Stroke by a Novel, Clot-dissolving Antibody$999,993
U44 · FY2012 · NS · contact PI
Reducing Stroke by a Novel, Clot-dissolving Antibody$300,000
U44 · FY2011 · NS · contact PI